Catalent Gets ADC Tech and Enters Fast-Growing Niche Market
Catalent says it will focus on providing technology for the ADC and biologics market as it becomes the latest CMO to invest in the field.
Archives for April 10, 2013
GE and iBio Confirm Fiocruz Vaccine Plant Project and Predict Future Collaborations
GE Healthcare and iBio are in talks about future projects after confirming they are working on a plant-based vaccine manufacturing site for Brazilian drugmaker Fiocruz/Bio-Manguinhosin.